Menopausal Hormone Therapy for the prevention of cardiovascular disease: Evidence-based customization

Boardman et al. provided this March an updated version of their 2013 Cochrane review [1], aiming to assess the effects of menopausal hormone therapy (MHT) for the prevention of cardiovascular disease in postmenopausal women. The authors concluded that treatment with MHT in postmenopausal women, for either primary or secondary prevention of cardiovascular disease, has little, if any, benefit and causes an increase in the risk of stroke and venous thromboembolic events.
Source: Maturitas - Category: Primary Care Authors: Tags: Editorial Source Type: research